3-hydroxyflavone has been researched along with Carcinoma, Lewis Lung in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, KS; Bae, HS; Kim, CH; Kim, SH; Ko, SG; Lee, EO; Lee, HJ; Lu, J | 1 |
Chabot, GG; Scherman, D; Seguin, J; Touil, YS | 1 |
Auzeil, N; Boulinguez, F; Chabot, GG; Regazzetti, A; Saighi, H; Scherman, D; Touil, YS | 1 |
Arnaud, P; Brossard, D; Chabot, GG; Crauste-Manciet, S; Ragelle, H; Scherman, D; Seguin, J | 1 |
Bessodes, M; Boyer, R; Brullé, L; Chabot, GG; Lu, YM; Mignet, N; Ramos Romano, M; Scherman, D; Seguin, J; Touil, YS | 1 |
5 other study(ies) available for 3-hydroxyflavone and Carcinoma, Lewis Lung
Article | Year |
---|---|
Mitochondria-cytochrome C-caspase-9 cascade mediates isorhamnetin-induced apoptosis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Lewis Lung; Caspase 9; Caspase Inhibitors; Cell Line, Tumor; Cell Proliferation; Cysteine Proteinase Inhibitors; Cytochromes c; Dose-Response Relationship, Drug; Female; Flavonols; Injections, Intraperitoneal; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mitochondria; Quercetin; Time Factors | 2008 |
Improved antiangiogenic and antitumour activity of the combination of the natural flavonoid fisetin and cyclophosphamide in Lewis lung carcinoma-bearing mice.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cell Cycle; Cell Line; Cell Movement; Cell Proliferation; Cell Survival; Cyclophosphamide; Endothelial Cells; Female; Flavonoids; Flavonols; Humans; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; NIH 3T3 Cells; Tubulin Modulators; Tumor Burden | 2011 |
Fisetin disposition and metabolism in mice: Identification of geraldol as an active metabolite.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Movement; Cell Survival; Collagen; Drug Combinations; Endothelial Cells; Female; Flavones; Flavonoids; Flavonols; Glucuronides; Laminin; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Proteoglycans | 2011 |
Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Biological Availability; Carcinoma, Lewis Lung; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Stability; Emulsions; Endothelial Cells; Excipients; Female; Flavonoids; Flavonols; Half-Life; Humans; Injections, Intraperitoneal; Injections, Intravenous; Mice; Mice, Inbred C57BL; Nanoparticles; Particle Size; Solubility; Solvents; Surface-Active Agents | 2012 |
Liposomal encapsulation of the natural flavonoid fisetin improves bioavailability and antitumor efficacy.
Topics: Animals; Antineoplastic Agents; Biological Availability; Carcinoma, Lewis Lung; Cell Line, Tumor; Cyclophosphamide; Female; Flavonoids; Flavonols; Liposomes; Mice; Mice, Inbred C57BL; Tumor Burden | 2013 |